IMMUNOPTOPHYLAXIS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN UNDER RISK OF HEAVY COURSE OF THE DISEASE: PRELIMINARY RESULTS OF IMPLEMENTING THE MOSCOW PROGRAM

IMMUNOPTOPHYLAXIS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN UNDER RISK OF HEAVY COURSE OF THE DISEASE: PRELIMINARY RESULTS OF IMPLEMENTING THE MOSCOW PROGRAM

The respiratory syncytial viral (RSV) infection is the leading cause of lower respiratory infections (bronchiolitis, pneumonia) in young children. Premature children and children with an inherent heart defect experience a heavy course of the infection, they require treatment in the resuscitation dep...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Korsunskiy, D. Y. Ovsannikov, D. N. Degtarev, I. N. Yakovleva, E. A. Degtareva, E. L. Bokeriya, E. S. Keshishan, O. V. Shamsheva, E. S. Pavlova, I. V. Krsheminskaya, Z. S. Igityan, H. M. Markhulia, E. D. Balashova, G. A. Alamovskaya, O. V. Mironyuk, O. V. Potapova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2012-06-01
Series:Педиатрическая фармакология
Subjects:
respiratory syncytial viral infection
immunoprophylaxis
palivizumab
children
risk groups.
Online Access:https://www.pedpharma.ru/jour/article/view/321
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pedpharma.ru/jour/article/view/321

Similar Items